Martin Tuchman Insider Trading Activity
Corporate InsiderDirector · CIK 939713
Martin Tuchman has been net-buying over the last 12 months with 17 purchases and 3 sales across 2 different companies.
BPRN is the most-traded position with 17 trades. The largest single transaction was a sale of FTAI for $34.8M on May 1, 2026.
Performance Scorecard
Forward stock performance after each transaction by Martin Tuchman. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | +5.9% | -2.2% | 75% | 24 |
| 90 days | +7.7% | — | 90% | 21 |
| 120 days | +5.0% | — | 100% | 21 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade Markers🔒 Subscribe to see trade entries
Pro members see exactly when Martin Tuchman bought and sold BPRN.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
May 4, 2026 | FTAI | Sell | 43,176 | $240.64 | $10.4M | −18.3% | Director | |
May 4, 2026 | FTAI | Sell | 67,500 | $241.99 | $16.3M | −24.3% | Director | |
May 1, 2026 | FTAI | Sell | 143,584 | $242.44 | $34.8M | −37.8% | Director | |
Nov 20, 2025 | BPRN | Buy | 2,000 | $32.30 | $65K | +17.2% | Director | |
Nov 19, 2025 | BPRN | Buy | 1,056 | $32.25 | $34K | +10.0% | Director | |
Nov 18, 2025 | BPRN | Buy | 2,000 | $32.30 | $65K | +23.4% | Director | |
Nov 17, 2025 | BPRN | Buy | 1,000 | $33.00 | $33K | +13.2% | Director | |
Nov 12, 2025 | BPRN | Buy | 5,000 | $33.00 | $165K | +196.2% | Director | |
Nov 11, 2025 | BPRN | Buy | 52 | $33.00 | $2K | +2.1% | Director | |
Nov 7, 2025 Filed 3d late | BPRN | Buy | 493 | $33.00 | $16K | +24.6% | Director | |
Nov 5, 2025 | BPRN | Buy | 3 | $32.60 | $97.8 | +0.1% | Director | |
Nov 4, 2025 | BPRN | Buy | 2,000 | $32.25 | $65K | — | Director | |
Sep 8, 2025 | BPRN | Buy | 10,000 | $33.00 | $330K | +1.6% | Director | |
Aug 20, 2025 | BPRN | Buy | 3,000 | $33.00 | $99K | +300.0% | Director | |
Aug 19, 2025 | BPRN | Buy | 1,000 | $32.90 | $33K | +0.8% | Director | |
Aug 7, 2025 | BPRN | Buy | 1,000 | $31.00 | $31K | — | Director | |
Aug 6, 2025 | BPRN | Buy | 1,539 | $31.03 | $48K | +1.3% | Director | |
Aug 5, 2025 | BPRN | Buy | 500 | $30.50 | $15K | +0.4% | Director | |
Aug 4, 2025 | BPRN | Buy | 2,000 | $30.18 | $60K | +1.7% | Director | |
Aug 1, 2025 | BPRN | Buy | 961 | $30.00 | $29K | +0.8% | Director | |
Jun 6, 2025 | BPRN | Buy | 1,044 | $30.47 | $32K | +0.9% | Director | |
Jun 5, 2025 | BPRN | Buy | 2,000 | $30.30 | $61K | +1.7% | Director | |
Jun 4, 2025 | BPRN | Buy | 2,000 | $30.40 | $61K | +1.8% | Director | |
Jun 3, 2025 | BPRN | Buy | 423 | $30.50 | $13K | +0.4% | Director |